|
|
Article: Lixte Biotechnology Holdings Announces New Appointment To Board Of Directors.
- Article from:
- PR Newswire
- Article date:
- November 29, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EAST SETAUKET, N.Y., Nov. 29 /PRNewswire-FirstCall/ -- John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD: LIXT) , announces the appointment of Stephen K. Carter, M.D. to the company's Board of Directors.
Dr. Carter is a highly experienced leader and administrator in cancer therapeutics and cancer drug development. For 13 years, he was associated with Bristol-Meyers Co. and Bristol-Meyers Squibb, Co. holding successively the positions of Senior Vice President, Anti-Cancer Research; President, Division of Pharmaceutical Research and Development, and ultimately Senior Vice President, Worldwide Clinical ...
Related newspaper, magazine, and journal articles:
|
|
Article: NATIONAL CITY BANK ELECTS JEFFREY M. BIGGAR, EXECUTIVE ...
PR Newswire;
April 1, 1994 ;
700+ words
... ... executive; J. Andrew Dunham to senior vice president, bank investment/funding; and David C. Fynn to senior vice president, regulatory risk. Profile ... group in October 1993 as senior vice president with corporate-wide responsibilities ...
|
|